Ligand Pharmaceuticals Inc (LGND)

Change in Working Capital

-$2.44M

TTM · Period ending: · USD

LGND logo

LGND Change in Working Capital

Latest reported-$2.44M
LGND Change in Working Capital ($3.20M → -$2.44M)
High-resolution chart · PNG

LGND change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Change in Working Capital — Annual fiscal periods (USD)
Period endingChange in Working Capital (USD)
-12,665,000
19,356,000
-34,402,000
65,677,000
-52,164,000
-10,064,000
-4,215,000
-38,854,000
-11,438,000
-10,620,000
821,000
-10,949,000
-702,000
-2,768,000
-5,875,000
-24,738,000
-18,329,000
-1,306,000
-55,832,000
-82,661,000
26,635,000
41,192,000
14,863,000
-6,813,000
-42,000
7,741,000
-8,700,000
-1,500,000
12,100,000
-4,000,000
1,400,000
3,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.